4//SEC Filing
KROLL MARK W 4
Accession 0001127602-22-021087
CIK 0000313143other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:33 PM ET
Size
4.8 KB
Accession
0001127602-22-021087
Insider Transaction Report
Form 4
KROLL MARK W
Director
Transactions
- Sale
Common Stock
2022-08-15$73.71/sh−8,016$590,859→ 16,231 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.41 to $74.25, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]This number includes unvested restricted stock units previously reported.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001259254
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:33 PM ET
- Size
- 4.8 KB